Targeting tumor microenvironment with antibody-guided IL-2 pro-cytokine promotes and rejuvenates dysfunctional CD8+ T cells

Signal Transduct Target Ther. 2023 Jul 12;8(1):268. doi: 10.1038/s41392-023-01463-y.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Antibodies
  • CD8-Positive T-Lymphocytes
  • Cytokines*
  • Humans
  • Interleukin-2* / genetics
  • Tumor Microenvironment / genetics

Substances

  • Antibodies
  • Cytokines
  • Interleukin-2